Aurinia Pharmaceuticals AUPH Visp, Switzerland — Total
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's visp, switzerland — total.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's visp, switzerland — total?
- Aurinia Pharmaceuticals (AUPH) reported visp, switzerland — total of $64.7M in Q1 2026.
- How has Aurinia Pharmaceuticals's visp, switzerland — total changed year-over-year?
- Aurinia Pharmaceuticals's visp, switzerland — total decreased by 9.3% year-over-year, from $71.3M to $64.7M.
- What does visp, switzerland — total mean?
- Represents the aggregate financial value or operational output attributed to the Visp, Switzerland geographic segment. This metric serves as a high-level indicator of the segment's overall contribution to the company's financial position or operational footprint. It is used to evaluate the relative importance and performance of this specific region within the broader corporate structure.